Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction

Cytotherapy

Volumn 10, Issue 5, 2008, Pages 469-478

  Du, Y Y ^a   Zhou, Sheng Hua ^a   Zhou, T ^a   Su, H ^a   Pan, H W ^a   Du, W H ^a   Liu, B ^a   Liu, Q M ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Immuno inflammatory response; Immunomodulation; Mesenchymal stromal cells; Myocardial infarction; Transplantation

Indexed keywords

BROXURIDINE; CRYSTAL VIOLET; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LYMPHOCYTOTOXICITY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN LYMPHOCYTE; THERAPY EFFECT; WESTERN BLOTTING;

EID: 53249127066     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802129893     Document Type: Article

References (37)

1. Schuleri, KH, Boyle, AJ and Hare, JM. (2007) Mesenchymal stem cells for cardiac regenerative therapy. Bone Marrow-Derived Progenitors, pp. 195-218. Springer-Verlag, Berlin, Heidelberg
2. Orlic, D. (2002) Adult BM stem cells regenerate mouse myocardium. Cytotherapy, 4, pp. 521-525.
3. Orlic, D. (2003) Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann NY Acad Sci, 996, pp. 152-157.
4. Zhang, S., Zhang, P. Guo, J. et al. (2004) Enhanced cytoprotection and angiogenesis by bone marrow cell transplantation may contribute to improved ischemic myocardial function. Eur J Cardiothorac Surg, 25, pp. 188-195.
5. Berry, MF, Engler, AJ Woo, YJ et al. (2006) Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol, 290, p. H2196.
6. Grinnemo, KH, Mansson-Broberg, A. Leblanc, K. et al. (2006) Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med, 38, pp. 144-153.
7. Alvarez-Dolado, M., Pardal, R. Garcia-Verdugo, JM et al. (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 425, pp. 968-973.
8. Nygren, JM, Jovinge, S. Breitbach, M. et al. (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med, 10, pp. 494-501.
9. Uemura, R., Xu, M. Ahmad, N. et al. (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res, 98, pp. 1414-1421.
10. Frangogiannis, NG, Smith, CW and Entman, ML. (2002) The inflammatory response in myocardial infarction. Cardiovasc Res, 53, pp. 31-47.
11. Liao, YH and Cheng, X. (2006) Autoimmunity in myocardial infarction. Int J Cardiol, 112, pp. 21-26.
12. Neumann, FJ, Ott, I. Gawaz, M. et al. (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation, 92, pp. 748-755.
13. Le Blanc, K. (2003) Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy, 5, pp. 485-489.
14. Le Blanc, K. (2006) Mesenchymal stromal cells: Tissue repair and immune modulation. Cytotherapy, 8, pp. 559-561.
15. Ma, J., Ge, J. Zhang, S. et al. (2005) Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol, 100, pp. 217-223.
16. Varda-Bloom, N., Leor, J. Ohad, DG et al. (2000) Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol, 32, pp. 2141-2149.
17. Rasmusson, I. (2006) Immune modulation by mesenchymal stem cells. Exp Cell Res, 312, pp. 2169-2179.
18. Uccelli, A., Pistoia, V. and Moretta, L. (2007) Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol, 28, pp. 219-226.
19. Uccelli, A., Moretta, L. and Pistoia, V. (2006) Immunoregulatory function of mesenchymal stem cells. Eur J Immunol, 36, pp. 2566-2573.
20. Amado, LC, Saliaris, AP Schuleri, KH et al. (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA, 102, pp. 11474-11479.
21. Makkar, RR, Price, MJ Lill, M. et al. (2005) Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther, 10, pp. 225-233.
22. Tse, WT, Pendleton, JD Beyer, WM et al. (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation, 75, pp. 389-397.
23. Klyushnenkova, E., Mosca, JD Zernetkina, V. et al. (2005) T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J Biomed Sci, 12, pp. 47-57.
24. Djouad, F., Charbonnier, LM Bouffi, C. et al. (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells, 25, pp. 2025-2032.
25. Ramasamy, R., Fazekasova, H. Lam, EW et al. (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation, 83, pp. 71-76.
26. Nian, M., Lee, P. Khaper, N. et al. (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res, 94, pp. 1543-1553.
27. Elahi, AW, Vijayakumar, AN Lichstein, E. et al. (2001) Interplay of antibody and T cell responses in acute myocardial infarction. J Lab Clin Med, 138, pp. 112-118.
28. de Scheerder, IK, de Buyzere, ML Delanghe, JR et al. (1989) Anti-myosin humoral immune response following cardiac injury. Autoimmunity, 4, pp. 51-58.
29. Maisel, A., Cesario, D. Baird, S. et al. (1998) Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res, 82, pp. 458-463.
30. Beyth, S., Borovsky, Z. Mevorach, D. et al. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, pp. 2214-2219.
31. Jiang, XX, Zhang, Y. Liu, B. et al. (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 105, pp. 4120-4126.
32. Sugano, M., Tsuchida, K. Hata, T. et al. (2004) In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. FASEB J, 18, pp. 911-913.
33. Capsoni, F., Minonzio, F. Mariani, C. et al. (1998) Development of phagocytic function of cultured human monocytes is regulated by cell surface IL-10. Cell Immunol, 189, pp. 51-59.
34. Kaur, K., Sharma, AK Dhingra, S. et al. (2006) Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol, 41, pp. 1023-1030.
35. Li, B., Liao, YH Cheng, X. et al. (2006) Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol, 111, pp. 247-255.
36. Schottelius, AJ, Mayo, MW Sartor, RB et al. (1999) Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem, 274, pp. 31868-31874.
37. Thum, T., Bauersachs, J. Poole-Wilson, PA et al. (2005) The dying stem cell hypothesis: Immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol, 46, pp. 1799-1802.